Identification of potent non-peptide somatostatin antagonists with sst3 selectivity

Journal of Medicinal Chemistry

Volumn 44, Issue 18, 2001, Pages 2990-3000

  Poitout, L ^a   Roubert, P ^a   Contour Galcera M O ^a   Moinet, C ^a   Lannoy, J ^a   Pommier, J ^a   Plas, P ^a   Bigg, D ^a   Thurieau, C ^a  

^a Institut Henri Beaufour   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CARBOLINE DERIVATIVE; BN 81644; BN 81674; CYCLIC AMP; IMIDAZOLE DERIVATIVE; RECEPTOR SUBTYPE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; DRUG IDENTIFICATION; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; NONHUMAN; RECEPTOR AFFINITY; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; CARBOLINES; CHO CELLS; CRICETINAE; CYCLIC AMP; HUMANS; LIGANDS; RADIOLIGAND ASSAY; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035974773     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0108449     Document Type: Article

References (53)

1. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
2. Somatostatin (second of two parts)
3. Somatostatin
4. Somatostatin in the central nervous system: Physiology and pathological modifications
5. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion
6. Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone
7. The role of somatostatin and its analogs in the diagnosis and treatment of tumors
8. Brain somatostatin: Receptor-coupled transducing mechanisms and role in cognitive functions
9. Somatostatin and thyrotropin releasing hormone: Central effect on sleep and motor system
10. Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei
11. Somatostatin selectively inhibits noradrenaline release from hypothalamic neurones
12. Molecular biology of somatostatin receptors
13. Cloned somatostatin receptors: Identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides
14. Characterization of cloned human somatostatin receptor SSTR5
15. Specific inhibition of rat pancreatic insulin and glucagon release by receptor-selective somatostatin analogues
16. SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
17. Lanreotide acetate
18. Conformationally restricted bicyclic analogues of somatostatin
19. De novo design and synthesis of somatostatin non peptide peptidomimetics utilizing β-D-glucose as a novel scaffolding
20. Design, synthesis and binding affinity of a nonpeptide mimic of somatostatin
21. Design, synthesis and binding affinities of novel non peptide mimics of somatostatin/sandostatin
22. A non-peptide ligand for the somatostatin receptor having a benzodiazepinone structure
23. 4 selectivity: Synthesis and structure-activity relationships of thioureas
24. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry
25. A combinatorial approach towards the discovery of non-peptide, subtype-selective somatostatin receptor ligands
26. 2) agonists
27. Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2
28. 3 receptor
29. The pictet-spengler condensation: A new direction for an old reaction
30. Chemical library purification strategies based on principles of complementary molecular reactivity and molecular recognition
31. Peptides azoles: A new class of biologically-active dipeptide mimics
32. Synthetic approaches to the 'azole' peptide mimetics
33. Structure and spectral properties of β-carbolines. Part 4. Synthesis of the new ring system: 9, 10, 15, 15b-tetrahydroindolo[1′,2′:4,3]pyrazino[2,1-a]-carbol-in- 7(6H)-one
34. Identification and characterisation of novel somatostatin antagonists
35. Identification and characterisation of novel somatostatin antagonists, erratum
36. Highly potent cyclic disulfide antagonists of somatostatin
37. Potent antagonists of somatostatin: Synthesis and biology
38. SST3-selective potent peptidic somatostatin receptor antagonists
39. Optimization of a somatostatin mimetic via constrained amino acid and backbone incorporation
40. Two aminoacids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS201-995 for the SSTR2 somatostatin receptor
41. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat
42. The elusive nature of cerebellar somatostatin receptors: Studies in rat, monkey and human cerebellum
43. Distribution of somatostatin receptor messenger rnas in the rat gastrointestinal tract
44. Expression and coupling of somatostatin receptors in rat adrenal (PC12) and pituitary (GC) cell lines
45. Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatin
46. Somatostatin increases mitogen-induced IL-2 secretion and proliferation of human jurkat T cells via Sst3 receptor isotype
47. Subtype-selective induction of wild-type P53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3
48. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney
49. Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase
50. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase
51. Cloning and characterization of a fourth human somatostatin receptor
52. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
53. Increased cyclic AMP in cultured vascular smooth muscle cells and relaxation of aortic strips by parathyroid hormone